Correlation Between Cingulate Warrants and Janux Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and Janux Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and Janux Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and Janux Therapeutics, you can compare the effects of market volatilities on Cingulate Warrants and Janux Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of Janux Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and Janux Therapeutics.

Diversification Opportunities for Cingulate Warrants and Janux Therapeutics

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Cingulate and Janux is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and Janux Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Janux Therapeutics and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with Janux Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Janux Therapeutics has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and Janux Therapeutics go up and down completely randomly.

Pair Corralation between Cingulate Warrants and Janux Therapeutics

Assuming the 90 days horizon Cingulate Warrants is expected to generate 1.9 times less return on investment than Janux Therapeutics. In addition to that, Cingulate Warrants is 1.64 times more volatile than Janux Therapeutics. It trades about 0.03 of its total potential returns per unit of risk. Janux Therapeutics is currently generating about 0.1 per unit of volatility. If you would invest  5,368  in Janux Therapeutics on September 12, 2024 and sell it today you would earn a total of  868.00  from holding Janux Therapeutics or generate 16.17% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy90.91%
ValuesDaily Returns

Cingulate Warrants  vs.  Janux Therapeutics

 Performance 
       Timeline  
Cingulate Warrants 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cingulate Warrants has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly weak technical and fundamental indicators, Cingulate Warrants may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Janux Therapeutics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Janux Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Janux Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Cingulate Warrants and Janux Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cingulate Warrants and Janux Therapeutics

The main advantage of trading using opposite Cingulate Warrants and Janux Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, Janux Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Janux Therapeutics will offset losses from the drop in Janux Therapeutics' long position.
The idea behind Cingulate Warrants and Janux Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device